Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.42 - $0.72 $4,200 - $7,200
10,000 Added 100.0%
20,000 $12,000
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $6,000 - $15,300
-10,000 Reduced 50.0%
10,000 $6,000
Q1 2023

May 12, 2023

BUY
$1.2 - $2.73 $12,000 - $27,300
10,000 Added 100.0%
20,000 $27,000
Q3 2022

Nov 10, 2022

BUY
$1.9 - $8.63 $19,000 - $86,300
10,000 New
10,000 $25,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.